HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.

Abstract
We sequenced from 5'-franking region to intron 1 (to 337 bp downstream from exon 1) of the UDP-glucuronosyltransferase (UGT) 1A9 gene prepared from 55 Japanese cancer patients. Seven single nucleotide polymorphisms (SNPs) were found. Two of them were UGT1A9 -118(T)n (n=10) and UGT1A9*5, and four were reported SNPs in intron 1 of UGT1A9 gene (89540C>T, 89549G>A, 89616T>A and 89710A>C). A novel SNP (89587T>C) was found. The sequence is as follows: SNP, 050824FujitaK001; Gene Name, UGT1A9; Accession Number, AF297093; Length, 25 bases; 5'-CCTTCTTGAAGAT/CATGTATTTATAA-3'. Two patients were heterozygous for the mutant allele, resulting in the allele frequency of 1.82%.
AuthorsKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, Wataru Yamamoto, Hisashi Endo, Keiji Kodama, Kazuhiro Araki, Toshimichi Miya, Masaru Narabayashi, Yasutsuna Sasaki
JournalDrug metabolism and pharmacokinetics (Drug Metab Pharmacokinet) Vol. 21 Issue 1 Pg. 79-81 (Feb 2006) ISSN: 1347-4367 [Print] England
PMID16547398 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • DNA, Neoplasm
  • UGT1A9 protein, human
  • Irinotecan
  • Glucuronosyltransferase
  • UDP-Glucuronosyltransferase 1A9
  • Camptothecin
Topics
  • Alleles
  • Antineoplastic Agents, Phytogenic (pharmacokinetics, therapeutic use)
  • Camptothecin (analogs & derivatives, pharmacokinetics, therapeutic use)
  • DNA, Neoplasm (genetics)
  • Exons (genetics)
  • Gene Frequency
  • Glucuronosyltransferase (genetics)
  • Humans
  • Introns (genetics)
  • Irinotecan
  • Japan (epidemiology)
  • Molecular Sequence Data
  • Mutation (genetics)
  • Neoplasms (genetics)
  • Polymorphism, Single Nucleotide (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • UDP-Glucuronosyltransferase 1A9

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: